Ambu
AMBU-B.COPrivate Company
Total funding raised: $200M
Overview
Ambu is a global leader in single-use medical devices, having fundamentally transformed procedural standards by introducing the world's first single-use flexible video endoscope in 2009. Its strategy centers on an integrated platform of single-use visualization tools for airway management and endoscopy, driving growth by addressing cross-contamination risks, high reprocessing costs, and workflow inefficiencies. The company is publicly traded and leverages its deep clinical evidence and platform stickiness to expand its market leadership.
Technology Platform
An integrated visualization and data management platform (aView 2 Advance / aBox 2) that serves as a central hub for a full suite of single-use endoscopes and airway management devices, enabling multi-device interoperability, Dual View functionality, and EHR connectivity.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Ambu competes with traditional reusable endoscopy giants (Olympus, Karl Storz) now launching single-use products, and with niche single-use specialists in specific segments. Its competitive edge lies in its dedicated single-use focus, broadest integrated platform, and extensive clinical evidence supporting its value proposition.
Company Timeline
Founded in Ballerup, Denmark
Initial Public Offering
Debt: $200.0M